As of December 2024, Corcept Therapeutics has a market cap of $5.71B. This makes Corcept Therapeutics the world's 1016th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $2.55B | -23.98% |
2023 | $3.35B | 59.92% |
2022 | $2.09B | 2.58% |
2021 | $2.04B | -24.31% |
2020 | $2.70B | 116.20% |
2019 | $1.25B | -9.43% |
2018 | $1.38B | -26.02% |
2017 | $1.86B | 148.76% |
2016 | $748.37M | 45.78% |
2015 | $513.34M | 66.00% |
2014 | $309.24M | -6.54% |
2013 | $330.89M | 124.48% |
2012 | $147.41M | -58.19% |
2011 | $352.54M | -11.40% |
2010 | $397.89M | 38.85% |
2009 | $286.57M | 172.55% |
2008 | $105.14M | -66.99% |
2007 | $318.52M | 151.22% |
2006 | $126.79M | -66.30% |
2005 | $376.25M | -41.60% |
2004 | $644.26M | - |